Tanya Simuni, M.D.

Dr. Tanya Simuni is the Arthur C. Nielsen Jr.  Professor of Neurology and Director of the Parkinson’s Disease and Movement Disorders Center at Northwestern University. She leads a comprehensive movement disorders center at Northwestern University Feinberg School of Medicine that is recognized by the Parkinson’s Foundation, Huntington Disease Society of America and Wilson’s Foundation as a Center of Excellence and serves as a training model in the region.

She is internationally recognized expert in design and implementation of PD clinical trials focused on disease modification. She is the lead author of the new biological definition and staging framework of Neuronal Synuclein disease (NSD).  She serves on the leadership team of the MJFF sponsored PPMI study, the largest PD biomarker initiative where she also serves as the Principal Investigator for the first platform trial to test therapeutics in biologically defined prodromal population (P2P).  She serves on a number of Steering Committees for the PD international clinical trials, several committees of the Parkinson Study Group and the Parkinson Foundation. Dr. Simuni is the site PI for the Network for Excellence in Neuroscience Clinical Trials (NEXT). She has more than 150 publications in peer-reviewed scientific journals, and she has lectured nationally and internationally on PD and other movement disorders.  In addition to her research career, Dr Simuni is highly committed to education of the next generation of physicians and patient advocacy.

Dr. Simuni is an active member of the American Academy of Neurology, American Neurological Association, the Movement Disorders Society as well as the Parkinson’s Study Group.